Axogen, Inc. — Director's Dealing 2021

May 28, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Axogen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2021-05-26

Reporting Person: Freitag Gregory Gene (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-05-26	Common Stock	M	22954	$3.67	Acquired	251306	Direct
2021-05-26	Common Stock	M	9000	$5.09	Acquired	260306	Direct
2021-05-26	Common Stock	M	6000	$5.45	Acquired	266306	Direct
2021-05-26	Common Stock	M	15000	$5.45	Acquired	281306	Direct
2021-05-26	Common Stock	M	50000	$8.95	Acquired	331306	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-05-26	Employee Stock Option (right to purchase)	$3.67	M	22954	Disposed	2021-12-29	Common Stock (22954.0)	Direct
2021-05-26	Employee Stock Option (right to purchase)	$5.09	M	9000	Disposed	2022-12-29	Common Stock (9000.0)	Direct
2021-05-26	Employee Stock Option (right to purchase)	$5.45	M	6000	Disposed	2023-05-26	Common Stock (6000.0)	Direct
2021-05-26	Stock Option (right to purchase)	$5.45	M	15000	Disposed	2023-05-26	Common Stock (15000.0)	Direct
2021-05-26	Employee Stock Option (right to purchase)	$8.95	M	50000	Disposed	2026-12-29	Common Stock (50000.0)	Direct

Footnotes

F1: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2018 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2015 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

F2: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2019 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2016 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

F3: All shares of Common Stock underlying the employee stock option became fully vested on May 26, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on May 26, 2017(12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.

F4: All shares of Common Stock underlying the employee stock option became fully vested on December 31, 2016. The option vested in two equal installments beginning on September 30, 2016, and became fully vested on December 31, 2016.

F5: All shares of Common Stock underlying the employee stock option became fully vested on December 29, 2020 (4 years from the option grant date) based upon a vesting schedule whereby 25% of the aggregate shares vested on December 29, 2017 (12 months from the option grant date) and an additional 12.5% of the aggregate shares vested each 6 months thereafter.